Company / PP&E per Share
KalVista Pharmaceuticals, Inc. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.05
FY2025
5-year range
$0.04 / $0.10
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#118 of 191
Health Care
What the data says
At $0.05, KalVista Pharmaceuticals, Inc.'s pp&e per share ranks #118 of 191 in the Health Care sector. PP&E per Share returned to growth in FY2025 after 5 years of decline, reaching $0.05.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of -16.9%.
Declined from $0.08 to $0.05 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -19.4%
- 5-Year CAGR
- -16.9%
- 10-Year CAGR
- -
Sector benchmark
#118 of 191 in Health CareTop 62% of 191This company $0.05 Sector average $18.90
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 4.2% year-over-year.
- Ranks #118 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | +4.2% |
| FY2024 | $0.04 | -44.0% |
| FY2023 | $0.08 | -10.1% |
| FY2022 | $0.09 | -11.1% |
| FY2021 | $0.10 | -15.1% |
| FY2020 | $0.12 | -47.1% |
| FY2019 | $0.22 | +18.2% |
| FY2018 | $0.19 | +1911.4% |
| FY2017 | $0.01 | -41.0% |
| FY2016 | $0.02 | -99.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026